Skip to content

Restore is on the waitlist.Join first

Better YearsPet Health

Science

Peptide therapy for dogs: signals, not collagen treats

8 min read ·

Emerging Research

Search peptides for dogs and you will get collagen chews, Instagram recovery clips, and the occasional research paper. Peptide therapy for dogs sounds clinical. Most of what ranks is not.

Peptides are short chains of amino acids. Some act as biological signals. That is true in biochemistry and still not a license to call any vial a therapy. Therapy is a word veterinarians earn. We use protocol, wellness, and evidence badges on purpose.

Three things people collapse into one phrase

Nutrition peptides, like collagen in a treat. Research peptides, like BPC-157, studied mostly outside companion-dog clinical programs. Licensed veterinary drugs, which belong in a clinic. Better Years is building in the second bucket, with the honesty the first and third already have to follow. TB-500 belongs in that research conversation too. It is not the product.

A wedge inside longevity, not a cult of compounds

The Dog Aging Project exists because aging in dogs is a real scientific subject, not a slogan. Peptides are one place the research is moving. Diagnostics, mobility, metabolic health, nutrition, and veterinary medicine belong in the same conversation. No single peptide is pet longevity.

How we will talk about it

Named compounds. Public evidence levels. No fabricated studies. No 'best peptides for dogs' listicle that ranks investigational tools as if they were kibble. Restore is injectable BPC-157. The Science page is the longer map, including the compounds we are watching and not selling.

Sources

  • The Dog Aging Project, Dog Aging Project Source

    A large, ongoing research program studying aging in companion dogs. Cited as category context, not as an endorsement of Better Years or Restore.

  • BPC-157 indexed literature, PubMed Source

    Published work is predominantly laboratory and rodent-model research, plus some canine pharmacokinetic and toxicology studies. A literature search is not a companion-dog efficacy trial. We classify companion-dog efficacy as preclinical.

  • Thymosin beta-4 indexed literature, PubMed Source

    TB-500 is discussed as a fragment related to thymosin beta-4. That is not FDA approval for dogs and not a proven clinical outcome.

Questions people actually ask

Online, the phrase mixes collagen chews, research peptides, and clinical veterinary drugs. Better Years uses it to mean named research peptides, described with an evidence level, as part of a pet longevity platform. That is not a licensed veterinary therapy unless a veterinarian says it is.